Literature DB >> 28125662

Serum Fatty Acids, Desaturase Activities and Abdominal Obesity - A Population-Based Study of 60-Year Old Men and Women.

Zayed D Alsharari1, Ulf Risérus1, Karin Leander2, Per Sjögren1, Axel C Carlsson3, Max Vikström2, Federica Laguzzi2, Bruna Gigante2,4, Tommy Cederholm1, Ulf De Faire2,5, Mai-Lis Hellénius5, Matti Marklund1.   

Abstract

pan class="Disease">Abdominal obesity is a key contributor of n>n class="Disease">metabolic disease. Recent trials suggest that dietary fat quality affects abdominal fat content, where palmitic acid and linoleic acid influence abdominal obesity differently, while effects of n-3 polyunsaturated fatty acids are less studied. Also, fatty acid desaturation may be altered in abdominal obesity. We aimed to investigate cross-sectional associations of serum fatty acids and desaturases with abdominal obesity prevalence in a population-based cohort study. Serum cholesteryl ester fatty acids composition was measured by gas chromatography in 60-year old men (n = 1883) and women (n = 2015). Cross-sectional associations of fatty acids with abdominal obesity prevalence and anthropometric measures (e.g., sagittal abdominal diameter) were evaluated in multivariable-adjusted logistic and linear regression models, respectively. Similar models were employed to investigate relations between desaturase activities (estimated by fatty acid ratios) and abdominal obesity. In logistic regression analyses, palmitic acid, stearoyl-CoA-desaturase and Δ6-desaturase indices were associated with abdominal obesity; multivariable-adjusted odds ratios (95% confidence intervals) for highest versus lowest quartiles were 1.45 (1.19-1.76), 4.06 (3.27-5.05), and 3.07 (2.51-3.75), respectively. Linoleic acid, α-linolenic acid, docohexaenoic acid, and Δ5-desaturase were inversely associated with abdominal obesity; multivariable-adjusted odds ratios (95% confidence intervals): 0.39 (0.32-0.48), 0.74 (0.61-0.89), 0.76 (0.62-0.93), and 0.40 (0.33-0.49), respectively. Eicosapentaenoic acid was not associated with abdominal obesity. Similar results were obtained from linear regression models evaluating associations with different anthropometric measures. Sex-specific and linear associations were mainly observed for n3-polyunsaturated fatty acids, while associations of the other exposures were generally non-linear and similar across sexes. In accordance with findings from short-term trials, abdominal obesity was more common among individuals with relatively high proportions of palmitic acid, whilst the contrary was true for linoleic acid. Further trials should examine the potential role of linoleic acid and its main dietary source, vegetable oils, in abdominal obesity prevention.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28125662      PMCID: PMC5270324          DOI: 10.1371/journal.pone.0170684

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

pan class="Disease">Abdominal obesity (AO) is a strong predictor of n>n class="Disease">cardiometabolic disease [1] and some cancer types[2, 3]. In particular, visceral obesity is a potential driver of insulin resistance and metabolic disorders[4]. The prevalence of AO is increasing [5, 6] and although genetic factors are influential, AO is largely determined by lifestyle [7]. Thus, lifestyle factors including diet might be key modifiable risk factors of AO[8, 9]. High intake of dietary fats has long been considered to promote AO, while recent studies suggest that the fatty acid (FA) compositing may be more important for modulating fat deposition and fat distribution [9, 10]. Diets high in saturated fatty acids (SFA) may promote the development of AO and metabolic syndrome [9-11], whereas high intake of polyunsaturated fatty acids (PUFA) may counteract body fat accumulation [9, 10]. In particular, linoleic acid (LA, 18:2n-6) and palmitic acid (PA, 16:0) have been reported to be associated with the degree of fat accumulation in both visceral and subcutaneous adipose tissue [9]. Apart from the potential role of dietary FA in AO, enzymes metabolizing FA may influence body fat storage, body weight[12], waist circumference, and obesity [13]. Stearoyl-CoA desaturase (SCD), Δ5-desaturase (D5D), and Δ6-desaturase (D6D) are together with elongases the main enzymes responsible for endogenous synthesis of monounsaturated FA and PUFA [14]. While SCD synthesizes monounsaturated FA from SFA, D5D and D6D catalyze the synthesis of long-chain PUFA, e.g., eicosapentaenoic acid (EPA) and docohexaenoic acid (DHA), from the two essential fatty acids, LA and α-linolenic acid (ALA). Observational studies investigating relationships between pan class="Gene">fat intake and AO or related outcomes have mostly relied on self-estimated food intake, which may be limited by e.g. reporting bias and inaccuracy of food databases [15]. FA compositions in diverse physiological compan>rtn>n class="Species">ments, e.g., serum cholesteryl esters (CE), partly reflect FA composition of the diet [13], and are thus useful biomarkers of dietary fat quality [15]. Essential fatty acids (LA and ALA) and long-chain n-3 PUFA (EPA and DHA) are among the more reliable biomarkers of fat intake while many endogenously synthesized FA are often considered to reflect intake less correctly. However, intake of PA is at least partly reflected in serum CE. As men and women differ in abdominal fat accumulation as well as FA compositions in diet and tissues, it is possible that associations of serum FA and desaturase activities with measures of AO are sex-specific. In addition, altered desaturase activities (e.g. SCD) may be involved in pathophysiology of AO, but such mechanisms require further investigation [12, 13]. We hypothesized that serum FA composition, partly reflecting dietary pan class="Gene">fat quality, and desaturase activities are related to abdominal n>n class="Gene">fat distribution, in a possible sex-dependent manner. We aimed to investigate cross-sectional associations of serum FA composition in CE and estimated desaturase activities with AO and anthropometric measures of abdominal adiposity in a large population-based cohort of 60-year-old Swedish men and women.

Methods

Study population

The cross-sectional study was conducted in a population-based cohort of 60-year-old pan class="Species">men and n>n class="Species">women [16]. Data from baseline investigations were collected between August 1997 and March 1999. Every third man and woman living in the Stockholm County, Sweden, and born between July 1, 1937 and June 30, 1938 was invited to participate, i.e., a total of 5460 subjects (2779 men and 2681 women), of which 78% (n = 4232; 2039 men and 2193 women) agreed to take part [17, 18]. All subjects underwent a physical examination that included anthropometric measurepan class="Species">ments and blood sampling [16]. Blood samples were drawn in the morning after overnight fasting and serum n>n class="Chemical">glucose, insulin, cholesterol, and triglycerides were analyzed as previously described [16, 17]. A comprehensive questionnaire regarding dietary habits, lifestyle factors, and medical history was completed by all participants. Smoking, education and physical activity were categorized as described previously [18], while alcohol intake was estimated in g/day based on responses to five questions concerning intake of beer, wine, and spirits[19]. The study was approved by the Ethical Committee at Karolinska Institutet and all participants gave their informed verbal consent as previously described in detail [20]. Forms for written consent were not in current use and thus written consent was not collected. After having received written information about the study, those who decided to participate were asked to contact a booking central in order to make an appointment to attend a physical examination. The procedure for collecting verbal consent was approved by the Ethical Committee at Karolinska Institutet.

Anthropometric measures

As previously described [17], body weight, height, sagittal abdominal diameter (pan class="Disease">SAD), waist circumference (WC), and hip circumference were recorded and utilized to calculate body mass index (BMI), sagittal abdominal diameter-to-height ratio (n>n class="Disease">SADHR), waist-hip ratio (WHR), waist circumference-to-height ratio (WCHR), and waist-hip-height ratio (WHHR). The definition of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) was used for defining AO: WC>102 cm for men and WC>88 cm for women[21].

Assessment of fatty acid composition

As previously described [18], FA composition in serum pan class="Chemical">cholesteryl esters (CE) was measured by gas chromatography[22]. Proportions of individual FA were expressed as percentages of all measured FA. Desaturase activities were estimated as FA ratios and were calculated as follows: n>n class="Gene">SCD = 16:1/16:0, D6D = 18:3n-6/18:2n-6, and D5D = 20:4n6/20:3n-6 [14].

Statistical methods

pan class="Species">Participants with missing data regarding exposures (FA and desaturase activities), AO measures (BMI, n>n class="Disease">SAD, WC, WHR, SADHR, WCHR, WHHR), or covariates (physical activity, education, smoking and alcohol intake) were excluded before analyses (S1 Fig). Shapiro-Wilk’s test was performed to examine the normality of distribution for continuous variables. Sex differences of continuous variables were evaluated by Student’s t-test or Wilcoxon-Mann-Whitney test for normally and non-normally distributed variables, respectively. Differences between men and women in binary and ordinal variables were assessed by χ2-test. Spearpan class="Species">man’s rank correlation coefficients were calculated between FA (as well as desaturases) and anthropometric measurements. Crude and multivariable-adjusted logistic regression models were utilized to calculate odds ratio (OR) and 95% CI for prevalence of AO. Similarly, crude and multivariable-adjusted linear regression models were employed to investigate associations of FAs and estimated desaturase activities with abdominal anthropometric measures. All analyses were performed in the total study population and in sex-specific strata. Serum FA (EPA, DHA, LA, and ALA) were investigated as categorical (quartiles) variables and overall trends were evaluated with quartile medians as exposure. Restricted cubic splines were utilized for evaluation of potential nonlinear associations[18]. Physical activity, alcohol intake, education, and smoking were included as covariates in the adjusted models. In analyses on the total study population, sex was also included as a covariate and sex-differences in overall trends were evaluated by including an interaction term of sex and exposure (sex-specific quartile median) in the models. Statistical analyses were carried out with STATA version 13.0 (STATA Corporation, TX, USA). P-values < 0.05 were considered significant.

Results

General characteristics

After excluding pan class="Species">participants with no data regarding serum FA, anthropometric measures, education, physical activity, n>n class="Chemical">alcohol intake and smoking habits, 3926 individuals (1899 men and 2027 women) of the cohort’s 4232 participants were included in the present study (S1 Fig). The proportion of individuals with abdominal obesity was greater (P<0.0001) among women (39%) compared to men (29%) (Table 1). Additional sex differences were found for all metabolic variables, degree of physical activity and smoking habits, where women were more sedentary and less likely to have been smokers than men. The correlation coefficients between the different anthropometric measures were between 0.50 and 0.96 (S1 Table).
Table 1

Anthropometrics, clinical measurements, lifestyle factors, serum cholesteryl ester FA, and estimated desaturase activity in the 60-year old men and women.

Total (n = 3926)Men (n = 1899)Women (n = 2027)P-value1
Abdominal obesity (%)342939<0.0001
BMI (kg/m2)26.3 (23.9–29.1)26.6 (24.4–29.1)25.9 (23.4–28.9)<0.0001
SAD (cm)20.6±2.921.5±2.719.8±2.8<0.0001
Waist circumference (cm)91.9±12.697.8±10.486.4±11.9<0.0001
Waist-hip ratio0.89±0.090.95±0.060.83±0.07<0.0001
SADHR (%)0.12±0.020.12±0.020.12±0.020.19
WCHR (%)0.54±0.070.55±0.060.53±0.07<0.0001
WHHR (m-1)0.52±0.050.54±0.040.51±0.05<0.0001
Total Cholesterol (mmol/L)5.9 (5.3–6.6)5.8 (5.1–6.4)6.1 (5.4–6.8)<0.0001
LDL Cholesterol2 (mmol/L)3.9±0.93.8±0.93.9±1.00.019
HDL Cholesterol (mmol/L)1.5±0.41.3±0.31.6±0.4<0.0001
Triglycerides (mmol/L)1.1 (0.8–1.6)1.2 (0.9–1.7)1.1 (0.8–1.5)<0.0001
Fasting insulin (mU/L)8.8 (6.6–12.3)9.2 (6.8–13.4)8.5 (6.4–11.5)<0.0001
Fasting glucose3 (mmol/L)5.2 (4.9–5.7)5.4 (5.0–5.9)5.1 (4.7–5.5)<0.0001
Alcohol intake (g/day)8.7 (2.7–17.6)14.0 (6.7–26.5)5.1 (1.3–11.6)<0.0001
Physical activity (%)<0.0001
    Sedentary111112
    Light intensity585561
    Medium intensity232521
    High intensity796
Smoking (%)<0.0001
    Never403446
    Current212022
    Former394632
Education (%)0.11
    ≤9 y282730
    9–12 y444543
    >12 y282827
Serum fatty acid, % of total FA
  Palmitic acid (PA, 16:0)11.4 (10.9–11.9)11.6 (11.1–12.0)11.2 (10.8–11.6)<0.0001
  Linoleic acid (LA, 18:2n6)48.4±4.248.4±4.248.4±4.10.97
  Alpha-linolenic acid (ALA, 18:3n3)0.88±0.200.87±0.200.90±0.20<0.0001
  Eicosapentaenoic acid (EPA, 20:5n3)1.88 (1.46–2.47)1.87 (1.44–2.46)1.89 (1.47–2.49)0.33
  Docohexaenoic acid (DHA, 22:6n3)0.92±0.250.91±0.250.93±0.240.0065
Desaturase activity, FA ratio
  SCD (16:1/16:0)0.30 (0.24–0.38)0.27 (0.22–0.35)0.32 (0.27–0.40)<0.0001
  D5D (20:4n6/20:3n6)9.0±2.29.0±2.29.0±2.20.41
  D6D (18:3n6/18:2n6)0.018 (0.013–0.023)0.017 (0.013–0.023)0.018 (0.014–0.024)0.0059

Values are mean±SD, median (IQR), or %. D5D, Δ5-desaturase; D6D, Δ6-desaturase; FA, fatty acid; SAD, sagittal abdominal diameter; SADHR, sagittal abdominal diameter-to-height ratio; SCD, stearoyl-CoA desaturase; WCHR, waist circumference-to-height ratio; WHR, waist-hip ratio; WHHR, waist-hip-height ratio.

1Sex differences of continuous variables were assessed by Student’s t-test (normally distributed variables) or Wilcoxon-Mann-Whitney test (skewed variables), while sex difference in categorical variables were evaluated by χ2 test.

Values are mean±SD, median (IQR), or %. pan class="Gene">D5D, Δ5n>n class="Gene">-desaturase; D6D, Δ6-desaturase; FA, fatty acid; SAD, sagittal abdominal diameter; SADHR, sagittal abdominal diameter-to-height ratio; SCD, stearoyl-CoA desaturase; WCHR, waist circumference-to-height ratio; WHR, waist-hip ratio; WHHR, waist-hip-height ratio. 1Sex differences of continuous variables were assessed by Student’s t-test (normally distributed variables) or Wilcoxon-pan class="Species">Mann-Whitney test (skewed variables), while sex difference in categorical variables were evaluated by χ2 test. Proportions of pan class="Chemical">ALA and n>n class="Chemical">DHA in serum CE as well as estimated activities of SCD and D6D were higher in women compared to men, who instead had greater proportion of serum PA (Table 1). PA correlated with the strongly intercorrelated EPA and DHA, while LA was inversely correlated with PA, EPA, and DHA (S1 Table). Serum ALA, correlated weakly with LA and EPA, and was inversely correlated with PA and DHA.

Palmitic acid and abdominal obesity

Serum pan class="Chemical">PA was associated with AO (Table 2 and Fig 1A) with no significant (P = 0.11) difference between n>n class="Species">men and women (S2 Table). Comparing extreme quartiles of serum PA, the multivariable-adjusted odds of prevalent abdominal obesitywere 46% higher in the highest PA quartile (Table 2). Serum PA correlated with all anthropometric measures in men, but only to WHR in women (S1 Table). After adjustment for potential confounders, PA was in general associated with anthropometric measures (Table 3 and S3 Table). All associations of PA with AO and anthropometric measures were generally non-linear (Fig 1A, Table 2 and S2 and S3 Tables).
Table 2

Associations of serum fatty acids with abdominal obesity.

Quartile of serum fatty acid
1234Ptrend2Pnon-linear3
Palmitic acid
Median (% of total FA)10.611.211.612.2
AO prevalence4, n (%)293 (30)313 (32)364 (37)370 (38)
OR (95% CI)5
Sex-adjusted1.00 (reference)1.10 (0.91–1.34)1.39 (1.15–1.68)1.43 (1.19–1.73)<0.00010.0097
Mutivariable-adjusted61.00 (reference)1.10 (0.90–1.33)1.40 (1.15–1.70)1.46 (1.20–1.77)<0.00010.0037
Linoleic acid
Median (% of total FA)43.847.449.952.9
AO prevalence4, n (%)446 (45)358 (36)291 (30)245 (25)
OR (95% CI)
Sex-adjusted1.00 (reference)0.69 (0.57–0.82)0.50 (0.42–0.61)0.40 (0.33–0.48)<0.0001<0.0001
Mutivariable-adjusted1.00 (reference)0.69 (0.57–0.83)0.50 (0.41–0.61)0.40 (0.32–0.49)<0.0001<0.0001
Alpha-linoleic acid
Median (% of total FA)0.670.810.931.10
AO prevalence4, n (%)376 (38)333 (34)324 (33)307 (31)
OR (95% CI)
Sex-adjusted1.00 (reference)0.83 (0.69–0.99)0.79 (0.66–0.95)0.73 (0.61–0.88)0.00130.07
Mutivariable-adjusted1.00 (reference)0.87 (0.72–1.05)0.80 (0.67–0.97)0.74 (0.61–0.89)0.00140.10
Eicosapentaenoic acid
Median (% of total FA)1.201.662.133.08
AO prevalence4, n (%)322 (33)361 (37)340 (35)317 (32)
OR (95% CI)
Sex-adjusted1.00 (reference)1.19 (0.99–1.44)1.09 (0.90–1.31)0.98 (0.81–1.18)0.390.32
Mutivariable-adjusted1.00 (reference)1.24 (1.02–1.50)1.19 (0.98–1.44)1.09 (0.90–1.33)0.750.13
Docohexaenoic acid
Median (% of total FA)0.650.820.971.19
AO prevalence4, n (%)374 (38)345 (35)343 (35)278 (28)
OR (95% CI)
Sex-adjusted1.00 (reference)0.88 (0.73–1.06)0.87 (0.72–1.05)0.64 (0.53–0.77)<0.00010.34
Mutivariable-adjusted1.00 (reference)0.94 (0.78–1.14)0.97 (0.80–1.17)0.75 (0.62–0.92)0.00880.18

1FA, fatty acid; OR, odds ratio; SAD, sagittal abdominal diameter; WC, waist circumference; WHR, waist-hip ratio.

2P for overall trend (Ptrend) was evaluated using logistic regression models with sex-specific quartile median as exposure.

3P for nonlinearity (Pnon-linear) was evaluated using restricted cubic splines.

4Abdominal obesity was defined as WC>88 cm in women and WC>102 cm in men.

5OR and 95% CI were evaluated using logistic regression models.

6Adjusted for sex, physical activity, alcohol intake, education and smoking.

Fig 1

Associations of serum palmitic acid (A) and linoleic acid (B) with abdominal obesity evaluated using restricted cubic spline. Associations were adjusted for sex, smoking, physical activity, education, and alcohol intake. Full and dashed lines represent odds ratios and their 95% CI, respectively, while dotted vertical lines correspond to 25th, 50th, and 75th percentiles of fatty acid proportions.

Table 3

Associations of serum fatty acids with abdominal obesity,.

Quartile of serum fatty acid
1234Ptrend3Pnon-linear4
Palmitic acid
SAD, cmObserved20.3 (20.2–20.5)20.5 (20.3–20.6)20.7 (20.5–20.9)20.9 (20.7–21.0)<0.00010.005
Adjusted520.3 (20.2–20.5)20.5 (20.3–20.6)20.7 (20.5–20.9)20.9 (20.7–21.0)<0.00010.002
WC, cmObserved90.6 (89.8–91.4)91.3 (90.6–92.1)92.5 (91.7–93.3)93.2 (92.4–94.0)<0.00010.0031
Adjusted90.6 (89.9–91.3)91.3 (90.6–92.0)92.5 (91.8–93.2)93.2 (92.6–93.9)<0.00010.0010
WHR, cmObserved0.88 (0.87–0.88)0.88 (0.88–0.89)0.89 (0.89–0.90)0.90 (0.89–0.90)<0.00010.0023
Adjusted0.88 (0.88–0.88)0.88 (0.88–0.89)0.89 (0.89–0.89)0.90 (0.89–0.90)<0.00010.0008
Linoleic acid
SAD, cmObserved21.3 (21.1–21.5)20.9 (20.7–21.1)20.3 (20.1–20.5)19.9 (19.7–20.0)<0.0001<0.0001
Adjusted21.3 (21.1–21.5)20.9 (20.7–21.0)20.3 (20.2–20.5)19.9 (19.7–20.0)<0.0001<0.0001
WC, cmObserved94.9 (94.1–95.7)93.0 (92.2–93.8)90.8 (90.1–91.6)88.9 (88.2–89.7)<0.0001<0.0001
Adjusted94.9 (94.2–95.6)93.0 (92.3–93.6)90.8 (90.1–91.5)88.9 (88.2–89.6)<0.0001<0.0001
WHR, cmObserved0.91 (0.90–0.91)0.89 (0.89–0.90)0.88 (0.88–0.89)0.87 (0.87–0.88)<0.00010.0007
Adjusted0.91 (0.90–0.91)0.89 (0.89–0.89)0.88 (0.88–0.89)0.87 (0.87–0.88)<0.00010.0011
Alpha-linoleic acid
SAD, cmObserved20.8 (20.6–21.0)20.6 (20.4–20.8)20.5 (20.3–20.7)20.4 (20.3–20.6)0.00110.21
Adjusted20.8 (20.6–21.0)20.6 (20.5–20.8)20.5 (20.3–20.7)20.4 (20.2–20.6)0.00120.42
WC, cmObserved92.9 (92.1–93.7)91.8 (91.0–92.6)91.5 (90.7–92.3)91.4 (90.7–92.1)0.00320.08
Adjusted92.8 (92.1–93.4)92.0 (91.3–92.7)91.5 (90.8–92.2)91.4 (90.7–92.1)0.0040.17
WHR, cmObserved0.89 (0.89–0.90)0.89 (0.88–0.89)0.89 (0.88–0.89)0.89 (0.88–0.89)0.510.0062
Adjusted0.89 (0.89–0.89)0.89 (0.88–0.89)0.89 (0.88–0.89)0.89 (0.88–0.89)0.500.019
Eicosapentaenoic acid
SAD, cmObserved20.4 (20.2–20.6)20.7 (20.5–20.9)20.7 (20.5–20.8)20.6 (20.4–20.7)0.620.0354
Adjusted20.4 (20.2–20.5)20.7 (20.5–20.8)20.7 (20.5–20.9)20.6 (20.4–20.8)0.130.0076
WC, cmObserved91.4 (90.6–92.2)92.3 (91.5–93.0)92.2 (91.4–93.0)91.8 (91.0–92.6)0.710.11
Adjusted91.1 (90.4–91.8)92.1 (91.4–92.8)92.3 (91.7–93.0)92.1 (91.4–92.8)0.110.0203
WHR, cmObserved0.89 (0.88–0.89)0.89 (0.89–0.90)0.89 (0.88–0.89)0.88 (0.88–0.89)0.100.42
Adjusted0.89 (0.88–0.89)0.89 (0.89–0.89)0.89 (0.88–0.89)0.89 (0.88–0.89)0.610.57
Docohexaenoic acid
SAD, cmObserved20.8 (20.6–21.0)20.6 (20.4–20.8)20.6 (20.4–20.8)20.4 (20.2–20.6)0.00160.31
Adjusted20.7 (20.5–20.8)20.6 (20.4–20.8)20.6 (20.4–20.8)20.5 (20.3–20.7)0.180.17
WC, cmObserved92.5 (91.8–93.3)92.1 (91.3–92.9)91.8 (91.0–92.7)91.2 (90.4–91.9)0.00800.30
Adjusted92.1 (91.4–92.8)92.0 (91.3–92.7)91.9 (91.3–92.6)91.6 (90.9–92.3)0.450.14
WHR, cmObserved0.89 (0.89–0.90)0.89 (0.88–0.89)0.89 (0.88–0.89)0.88 (0.88–0.89)<0.00010.61
Adjusted0.89 (0.89–0.90)0.89 (0.88–0.89)0.89 (0.88–0.89)0.88 (0.88–0.89)0.01440.91

1FA, fatty acid; SAD, sagittal abdominal diameter; WC, waist circumference; WHR, waist-hip ratio.

2Values are quartile means (95% CI).

3P for overall trend (Ptrend) was evaluated using linear regression models with sex-specific quartile median as exposure; for observed values sex was the only additional covariate, while for multivariable-adjusted trend sex, physical activity, alcohol intake, education and smoking were included as covariates.

4P for nonlinearity (Pnon-linear) was evaluated using restricted cubic splines

5Adjusted for physical activity, alcohol intake, education and smoking.

Associations of serum pan class="Chemical">palmitic acid (A) and n>n class="Chemical">linoleic acid (B) with abdominal obesity evaluated using restricted cubic spline. Associations were adjusted for sex, smoking, physical activity, education, and alcohol intake. Full and dashed lines represent odds ratios and their 95% CI, respectively, while dotted vertical lines correspond to 25th, 50th, and 75th percentiles of fatty acid proportions. pan class="Chemical">1FA, pan class="Chemical">fatty acid; OR, odds ratio; SAD, sagittal abdominal diameter; WC, waist circumference; WHR, waist-hip ratio. 2P for overall trend (Ptrend) was evaluated using logistic regression models with sex-specific quartile median as exposure. 3P for nonlinearity (Pnon-linear) was evaluated using restricted cubic splines. 4pan class="Disease">Abdominal obesity was defined as WC>88 cm in n>n class="Species">women and WC>102 cm in men. 5OR and 95% CI were evaluated using logistic regression models. 6Adjusted for sex, physical activity, pan class="Chemical">alcohol intake, education and smoking. pan class="Chemical">1FA, pan class="Chemical">fatty acid; SAD, sagittal abdominal diameter; WC, waist circumference; WHR, waist-hip ratio. 2Values are quartile means (95% CI). 3P for overall trend (Ptrend) was evaluated using linear regression models with sex-specific quartile median as exposure; for observed values sex was the only additional covariate, while for multivariable-adjusted trend sex, physical activity, pan class="Chemical">alcohol intake, education and smoking were included as covariates. 4P for nonlinearity (Pnon-linear) was evaluated using restricted cubic splines 5Adjusted for physical activity, pan class="Chemical">alcohol intake, education and smoking.

Linoleic acid and abdominal obesity

The prevalence of AO was significantly lower with higher LA levels (Table 2 and Fig 1B), with no difference between pan class="Species">men and n>n class="Species">women (P = 0.53) (S2 Table). The multivariable-adjusted odds of prevalent abdominal obesity were 60% lower in the highest compared to lowest LA quartile (Table 2). Serum LA was negatively correlated to all anthropometric measures in both sexes (S1 Table) and the inverse associations between LA and anthropometric measures remained after adjusting for potential confounders in men and women, separately (S3 Table) as well as combined (Table 3). Associations of LA with AO and anthropometric measures did not differ between men and women and were generally non-linear (Fig 1B, Table 2 and S2 Table).

n-3 PUFA and abdominal obesity

The prevalence of AO was lower with higher levels of serum pan class="Chemical">ALA (Table 2). However, there was a significant sex-difference (P = 0.0017), where an inverse association between n>n class="Chemical">ALA and AO was only observed in men when sexes were evaluated separately (S2 Table). Serum ALA was also negatively correlated with all anthropometric measures in men, but generally not in women (S1 Table). Results were similar after adjusting for potential confounders (S3 Table). In the total study population, ALA was inversely associated with SAD and WC but not with WHR (Table 3). Serum pan class="Chemical">EPA was not associated with AO and did not associate with any anthropometric measures in the total study population (Tables 2 and 3). However, there was a borderline significant sex-difference (P = 0.05) in the association between pan class="Chemical">EPA and AO; and EPA was associated with AO (P = 0.03), SAD (P = 0.03), and WC (P = 0.02) in women, when evaluated in sex-specific analyses using multivariable-adjusted models (S2 and S3 Tables). Serum pan class="Chemical">DHA was inversely associated with AO prevalence (Table 2), with no significant sex-differences (P = 0.23). When stratified by sex, however, an inverse association between n>n class="Chemical">DHA and AO was only observed in women (S2 Table). In addition, all anthropometric measures were inversely correlated with DHA among women (S1 Table), but after adjustment for potential confounders, DHA was inversely associated only with WHR, in the total study population (Table 3) and in women (S3 Table). The associations between n-3 pan class="Chemical">PUFA and AO and anthropometric measures, respectively, generally appeared to be linear (Tables 2 and 3).

Desaturase activities and abdominal obesity

The estimated activities of pan class="Gene">SCD and n>n class="Gene">D6D were associated with AO (Table 4), with no significant (P≥0.09) sex-differences (S4 Table). Both SCD and D6D activities were correlated (S1 Table) and associated with all anthropometric measures (Table 5), regardless of sex (S5 Table).
Table 4

Associations of estimated desaturase activities with abdominal obesity.

Quartile of estimated desaturase activity
1234Ptrend2Pnon-linear3
SCD
Median 16:1/16:0 ratio0.210.270.330.45
AO prevalence4, n (%)190 (19)269 (27)405 (41)476 (49)
OR (95% CI)5
Sex-adjusted1.00 (reference)1.58 (1.28–1.95)2.96 (2.42–3.63)4.00 (3.27–4.91)<0.0001<0.0001
Multivariable-adjusted61.00 (reference)1.61 (1.29–1.99)3.01 (2.44–3.72)4.14 (3.33–5.15)<0.0001<0.0001
D5D
Median 20:4n6/20:3n6 ratio6.718.119.4911.46
AO prevalence, n (%)431 (44)385 (39)289 (29)235 (24)
OR (95% CI)
Sex-adjusted1.00 (reference)0.82 (0.69–0.99)0.53 (0.44–0.64)0.40 (0.33–0.48)<0.00010.0004
Multivariable-adjusted1.00 (reference)0.84 (0.70–1.01)0.53 (0.44–0.64)0.40 (0.33–0.49)<0.00010.0005
D6D
Median 18:2n6/18:3n6 ratio0.0110.0160.0200.028
AO prevalence, n (%)231 (24)271 (28)356 (36)482 (49)
OR (95% CI)
Sex-adjusted1.00 (reference)1.24 (1.01–1.52)1.86 (1.53–2.27)3.19 (2.63–3.89)<0.00010.0021
Multivariable-adjusted1.00 (reference)1.19 (0.97–1.47)1.78 (1.45–2.17)3.00 (2.45–3.66)<0.00010.0038

1D5D, Δ5-desaturase; D6D, Δ6-desaturase; SAD, sagittal abdominal diameter; SCD, stearoyl-CoA desaturase WC, waist circumference; WHR, waist-hip ratio.

2P for overall trend (Ptrend) was evaluated using logistic regression models with sex-specific quartile median as exposure.

3P for nonlinearity (Pnon-linear) was evaluated using restricted cubic splines.

4Abdominal obesity was defined as WC>88 cm in women and WC>102 cm in men.

5OR and 95% CI were evaluated using logistic regression models.

6Adjusted for sex, physical activity, alcohol intake, education and smoking.

Table 5

Associations of estimated desaturase activities with anthropometric measures.,.

Quartile of estimated desaturase activity
1234Ptrend3Pnon-linear4
SCD
SAD, cmObserved19.5 (19.4–19.7)20.2 (20.0–20.3)21.0 (20.9–21.2)21.6 (21.4–21.8)<0.0001<0.0001
Adjusted519.5 (19.4–19.7)20.2 (20.0–20.3)21.0 (20.9–21.2)21.6 (21.5–21.8)<0.0001<0.0001
WC, cmObserved87.4 (86.7–88.2)90.5 (89.8–91.2)93.9 (93.1–94.7)95.8 (95.0–96.6)<0.0001<0.0001
Adjusted87.4 (86.7–88.1)90.5 (89.8–91.2)93.9 (93.2–94.5)95.9 (95.2–96.6)<0.0001<0.0001
WHR, cmObserved0.87 (0.86–0.87)0.88 (0.88–0.89)0.89 (0.89–0.90)0.91 (0.90–0.91)<0.0001<0.0001
Adjusted0.87 (0.86–0.87)0.88 (0.88–0.88)0.89 (0.89–0.90)0.91 (0.90–0.91)<0.0001<0.0001
D5D
SAD, cmObserved21.4 (21.2–21.6)20.9 (20.7–21.0)20.3 (20.1–20.5)19.8 (19.6–20.0)<0.0001<0.0001
Adjusted21.4 (21.2–21.6)20.9 (20.7–21.0)20.3 (20.1–20.5)19.8 (19.6–20.0)<0.0001<0.0001
WC, cmObserved95.2 (94.5–96.0)92.9 (92.1–93.7)90.7 (89.9–91.5)88.8 (88.0–89.5)<0.0001<0.0001
Adjusted95.1 (94.4–95.8)92.9 (92.3–93.6)90.7 (90.1–91.4)88.8 (88.2–89.5)<0.0001<0.0001
WHR, cmObserved0.90 (0.90–0.91)0.89 (0.89–0.90)0.88 (0.88–0.89)0.87 (0.87–0.88)<0.00010.0005
Adjusted0.90 (0.90–0.91)0.89 (0.89–0.90)0.88 (0.88–0.89)0.87 (0.87–0.88)<0.00010.0005
D6D
SAD, cmObserved19.7 (19.6–19.9)20.2 (20.1–20.4)20.8 (20.6–21.0)21.6 (21.4–21.8)<0.0001<0.0001
Adjusted19.8 (19.6–20.0)20.2 (20.1–20.4)20.8 (20.6–21.0)21.5 (21.4–21.7)<0.00010.0001
WC, cmObserved88.4 (87.6–89.1)90.5 (89.7–91.3)93.0 (92.2–93.7)95.8 (95.0–96.5)<0.0001<0.0001
Adjusted88.6 (88.0–89.3)90.5 (89.9–91.2)92.9 (92.2–93.6)95.5 (94.9–96.2)<0.0001<0.0001
WHR, cmObserved0.87 (0.86–0.87)0.88 (0.87–0.89)0.89 (0.89–0.90)0.91 (0.90–0.91)<0.0001<0.0001
Adjusted0.87 (0.87–0.88)0.88 (0.88–0.88)0.89 (0.89–0.90)0.90 (0.90–0.91)<0.0001<0.0001

1D5D, Δ5-desaturase; D6D, Δ6-desaturase; SAD, sagittal abdominal diameter; SCD, stearoyl-CoA desaturase; WC, waist circumference; WHR, waist-hip ratio.

2Values are quartile means (95% CI).

3P for overall trend (Ptrend) was evaluated linear regression models with sex-specific quartile median as exposure; for observed values sex was the only additional covariate, while for multivariable-adjusted trend sex,physical activity, alcohol intake, education and smoking were included as covariates.

4P for nonlinearity (Pnon-linear) was evaluated using restricted cubic splines.

5Values were adjusted for sex, physical activity, alcohol intake, education and smoking.

1pan class="Gene">D5D, Δ5n>n class="Gene">-desaturase; D6D, Δ6-desaturase; SAD, sagittal abdominal diameter; SCD, stearoyl-CoA desaturase WC, waist circumference; WHR, waist-hip ratio. 2P for overall trend (Ptrend) was evaluated using logistic regression models with sex-specific quartile median as exposure. 3P for nonlinearity (Pnon-linear) was evaluated using restricted cubic splines. 4pan class="Disease">Abdominal obesity was defined as WC>88 cm in n>n class="Species">women and WC>102 cm in men. 5OR and 95% CI were evaluated using logistic regression models. 6Adjusted for sex, physical activity, pan class="Chemical">alcohol intake, education and smoking. 1pan class="Gene">D5D, Δ5n>n class="Gene">-desaturase; D6D, Δ6-desaturase; SAD, sagittal abdominal diameter; SCD, stearoyl-CoA desaturase; WC, waist circumference; WHR, waist-hip ratio. 2Values are quartile means (95% CI). 3P for overall trend (Ptrend) was evaluated linear regression models with sex-specific quartile median as exposure; for observed values sex was the only additional covariate, while for multivariable-adjusted trend sex,physical activity, pan class="Chemical">alcohol intake, education and smoking were included as covariates. 4P for nonlinearity (Pnon-linear) was evaluated using restricted cubic splines. 5Values were adjusted for sex, physical activity, pan class="Chemical">alcohol intake, education and smoking. The estimated activity of pan class="Gene">D5D was inversely associated with AO (Table 4) and the association did not differ (P = 0.61) between n>n class="Species">men and women (S4 Table). Similarly, D5D was negatively correlated (S1 Table) and inversely associated with all anthropometric measures (Table 5 and S5 Table). The inverse association of D5D with WHR was somewhat stronger in women (P<0.05). Associations between desaturase activities and AO and anthropometric measures were generally non-linear (Tables 4 and 5). In general, associations of pan class="Chemical">fatty acids and desaturase activities with the novel anthropometric measures (n>n class="Disease">SADHR, WCHR, and WHHR) were similar to the associations with the more traditional measures SAD, WC, and WHHR (data not shown).

Discussion

The present study represents the largest cross-sectional study to date investigating the relationships between serum FA as biomarkers of dietary pan class="Gene">fat quality and AO in n>n class="Species">men and women. In line with current dietary guidelines, the results suggest that higher intake of PUFA, n-6 in particular, is associated with lower AO. A higher proportion of PA in serum was associated with higher prevalence of AO, whilst the contrary was found for serum LA. Associations between n-3 PUFA and AO were in general weaker and partly sex-specific. The positive and inverse associations with AO of pan class="Chemical">PA and LA, respectively, are supported by previous findings in observational studies and clinical trials. Serum n>n class="Chemical">PA has been correlated to measures of AO [13, 23] and in addition, PA in other compartments (i.e., plasma, erythrocytes, and skeletal muscle phospholipids) has been associated with increased liver fat [24], body fat percentage [25], and BMI [25]. In line with the present findings, high serum proportions of LA have been associated with lower SAD [13], WC [13], WHR [23], and BMI [13, 23]. When relations of serum PUFA with all-cause mortality and incident CVD were evaluated in the present study population, LA was inversely associated with all-cause mortality but not with CVD risk[18]. A recent meta-analysis reported lower LA in plasma phospholipids among overweight compared to normal weight participants [26] and LA concentration in LDL phosphatidylcholine has been associated with lower BMI and WC [27]. Findings from observational studies are supported by randomized controlled trials reporting greater accumulation of liver fat [9, 10], visceral fat [9], and total body fat [9] after consumption of SFA (high in PA) compared to PUFA (high in LA). The different effects on body composition by PUFA and SFA consumption may be partly due to PUFA-induced inhibition of de novo lipogenesis [9, 10]. Serum PA proportions are however not exclusively determined by PA intake, but also by endogenous FA metabolism (e.g., PA can be synthesized from especially sugars and other refined carbohydrates through de novo lipogenesis, and PA may undergo elongation or desaturation). However, the participants in the present study likely consumed a rather non-lipogenic diet with limited consumption of sugar-sweetened beverages and generally high (>30%) fat intake [28]. Other mechanisms behind the current associations may include greater oxidation of dietary PUFA versus SFA [29] or a potential obesogenic effect of SFA per se by up-regulation of 11β-hydroxysteroid-dehydrogenase type 1, promoting cortisol induced visceral fat accumulation [30]. In line with previous findings [23], serum pan class="Chemical">ALA was inversely associated with measures of AO in the present study. When stratified by sex, associations were only observed in n>n class="Species">men, maybe due to a weaker relationship between ALA intake and serum levels in women as we speculated earlier [18, 31]. In the present study population, long-chain n3 pan class="Chemical">PUFA in serum were associated with lower risk of incident CVD and all-cause mortality in a partly sex-dependent n>n class="Species">manner [18]. Here, serum DHA was inversely associated with AO in the total study population and in women but not in men. A recent meta-analysis reported lower plasma DHA in overweight compared to normal weight participants [26]. Effects on fat distribution by DHA per se may be limited and sex-specific associations of serum n3-PUFA and AO could partly reflect different dietary and lifestyle patterns in men and women. However, adjustments for lifestyle factors did not completely attenuate the associations between DHA and AO in the present study. Furthermore, dissimilarities in associations between men and women could be due to general differences in fat accumulation [32] or by hormone-dependent sex differences in lipid metabolism as suggested by human tracer trials [33], animal studies [34], and in vitro experiments [34]. Similar to the present study, activities of pan class="Gene">SCD and n>n class="Gene">D6D have been associated with AO [13] and subcutaneous adipose tissue [35]. Higher SCD activity has also been observed in individuals with increased liver fat content [24]. On the contrary, D5D activity estimated in plasma compartments has been inversely associated with AO [13] and subcutaneous adipose tissue [35]. In a recent meta-analysis, overweight individuals had higher D6D, but lower D5D activity estimates than those with normal weight [26]. Whether estimated desaturase activity affects body composition or rather is a marker of lifestyle and diet quality remains to be determined [36]. However, evidence of relationships between desaturases and body composition are supported by studies reporting associations between genetic variation of SCD and waist circumference [37] as well as genome-wide associations between D5D- and D6D-encoding genes and appendicular lean mass [38]. Considering the markedly elevated risk of OA in subjects with high estimated SCD activity, this finding warrants further research to examine if SCD activity is an important interventional target to reduce or prevent AO in humans. Some limitations of the present study should be highlighted. Results from this cross-sectional study support findings from randomized clinical trials and previous observational studies, but no inference of causation can be made from the current results due to the cross-sectional study design. The present cohort is restricted to 60-year-olds in Stockholm County and thus the results may not be representative for other populations. Assesspan class="Species">ments of serum FA and measures of AO were only performed once, which may lead to misclassifications due to intra-individual variation. However, the seemingly good reproducibility of serum n>n class="Chemical">PUFA [39] and anthropometry [40] as well as the consistency of results for different anthropometric measures suggest that these are not chance findings. Estimated desaturase activities may imperfectly reflect the in vivo desaturase activities although good agreement between FA ratios and more directly measured activity has been reported previously [41]. As FA proportions were utilized in the present study, it cannot be concluded that associations of single FA were independent of other FA (e.g., whether AO is associated with low LA consumption or high intake of PA and/or PA precursors). However, findings from trials suggest that dietary LA more effectively prevents abdominal fat accumulation compared to PA [9, 10]. In the present study, fatty acid composition was assessed in cholesterol esters and it cannot be excluded that the results would have been slightly different if we used compartment, e.g. phospholipids. Although fatty acid proportions in cholesterol esters and phospholipids generally correlate strongly [42], phospholipids comprise a larger fatty acid pool and proportions of palmitic acid in particular do differ between these two circulating compartments. Furthermore, it can be argued to what degree the anthropometric measures utilized distinguish between different types of abdominal fat (e.g., subcutaneous and visceral). Finally, residual confounding cannot be excluded. A major strength of the study is the use of a large population-based cohort with high participation rate assessing serum FA composition. Biomarkers can provide a more objective estimate of dietary pan class="Gene">fat composition compan>red to traditional assessn>n class="Species">ment methods based on self-reports. Associations of serum FA and desaturases with AO were evaluated by calculating odds ratios of AO defined by common thresholds as well as by assessing linear and nonlinear relationships with several anthropometric measures of AO. Finally, the inclusion of both men and women allowed investigations of sex-specific relationships.

Conclusion

Serum proportions of pan class="Chemical">fatty acids, partly reflecting dietary n>n class="Gene">fat intake, were associated with abdominal obesity in this large-scale population-based study and the associations were to some extent sex-specific. The most abundant serum fatty acid, linoleic acid, was strongly and inversely associated with abdominal obesity in both men and women. Contrary, a high serum proportion of palmitic acid, a major saturated fatty acid, was linked to higher odds of abdominal obesity and greater levels of all anthropometric measures. Docohexaenoic acid and α-linoleic acid were inversely associated with AO, in a partly sex-specific manner. Overall, these findings support those of recent interventional and experimental studies suggesting that a higher relative intake of polyunsaturated fatty acids (especially linoleic acid) from vegetable oils, associates with decreased abdominal adiposity. These findings are therefore coherent with current dietary guidelines regarding partial replacement of saturated fats with polyunsaturated fatty acids, especially in the light of the high and increasing prevalence of abdominal obesity and related diseases (e.g., diabetes and cardiovascular disease). In accordance with previous studies, fatty acid desaturase activities were altered in people with abdominal obesity.

Participant flow chart.

pan class="Species">Participants with no missing data regarding exposures (serum n>n class="Chemical">fatty acid and desaturase activities), outcomes (abdominal obesity measures), or covariates (physical activity, education, smoking and alcohol intake) were included for statistical analysis. (PDF) Click here for additional data file.

Spearman’s rank correlation coefficients between anthropometric measurements, serum fatty acids, and estimated desaturase activities.

(PDF) Click here for additional data file.

Associations of serum fatty acids with abdominal obesity in men and women.

(PDF) Click here for additional data file.

Associations of serum fatty acids with anthropometric measures in men and women.

(PDF) Click here for additional data file.

Associations of estimated desaturase activities with abdominal obesity.

(PDF) Click here for additional data file.

Associations of estimated desaturase activities with anthropometric measures in men and women.

(PDF) Click here for additional data file.
  40 in total

1.  Sex differences in lipid and glucose kinetics after ingestion of an acute oral fructose load.

Authors:  Christel Tran; Delphine Jacot-Descombes; Virgile Lecoultre; Barbara A Fielding; Guillaume Carrel; Kim-Anne Lê; Philippe Schneiter; Muriel Bortolotti; Keith N Frayn; Luc Tappy
Journal:  Br J Nutr       Date:  2010-06-14       Impact factor: 3.718

2.  Serum fatty acid composition and insulin resistance are independently associated with liver fat markers in elderly men.

Authors:  Helena Petersson; Johan Arnlöv; Björn Zethelius; Ulf Risérus
Journal:  Diabetes Res Clin Pract       Date:  2010-03       Impact factor: 5.602

3.  Are the recent secular increases in the waist circumference of adults independent of changes in BMI?

Authors:  David S Freedman; Earl S Ford
Journal:  Am J Clin Nutr       Date:  2015-01-07       Impact factor: 7.045

4.  Skeletal muscle membrane lipid composition is related to adiposity and insulin action.

Authors:  D A Pan; S Lillioja; M R Milner; A D Kriketos; L A Baur; C Bogardus; L H Storlien
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

5.  Differential oxidation of individual dietary fatty acids in humans.

Authors:  J P DeLany; M M Windhauser; C M Champagne; G A Bray
Journal:  Am J Clin Nutr       Date:  2000-10       Impact factor: 7.045

6.  Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial.

Authors:  Helena Bjermo; David Iggman; Joel Kullberg; Ingrid Dahlman; Lars Johansson; Lena Persson; Johan Berglund; Kari Pulkki; Samar Basu; Matti Uusitupa; Mats Rudling; Peter Arner; Tommy Cederholm; Håkan Ahlström; Ulf Risérus
Journal:  Am J Clin Nutr       Date:  2012-04-04       Impact factor: 7.045

7.  Polyunsaturated Fat Intake Estimated by Circulating Biomarkers and Risk of Cardiovascular Disease and All-Cause Mortality in a Population-Based Cohort of 60-Year-Old Men and Women.

Authors:  Matti Marklund; Karin Leander; Max Vikström; Federica Laguzzi; Bruna Gigante; Per Sjögren; Tommy Cederholm; Ulf de Faire; Mai-Lis Hellénius; Ulf Risérus
Journal:  Circulation       Date:  2015-06-17       Impact factor: 29.690

8.  Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans.

Authors:  Fredrik Rosqvist; David Iggman; Joel Kullberg; Jonathan Cedernaes; Hans-Erik Johansson; Anders Larsson; Lars Johansson; Håkan Ahlström; Peter Arner; Ingrid Dahlman; Ulf Risérus
Journal:  Diabetes       Date:  2014-02-18       Impact factor: 9.461

9.  Desaturation and elongation of Fatty acids and insulin action.

Authors:  B Vessby; I-B Gustafsson; S Tengblad; M Boberg; A Andersson
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

10.  Abdominal adiposity distribution in diabetic/prediabetic and nondiabetic populations: a meta-analysis.

Authors:  Jane J Lee; S Natasha Beretvas; Jeanne H Freeland-Graves
Journal:  J Obes       Date:  2014-11-26
View more
  11 in total

1.  Circulating n-3 fatty acids and linoleic acid as indicators of dietary fatty acid intake in post-myocardial infarction patients.

Authors:  K Pertiwi; D E Kok; A J Wanders; J de Goede; P L Zock; J M Geleijnse
Journal:  Nutr Metab Cardiovasc Dis       Date:  2019-01-09       Impact factor: 4.222

2.  Individual fatty acids in erythrocyte membranes are associated with several features of the metabolic syndrome in obese children.

Authors:  Sara Bonafini; Angela Tagetti; Rossella Gaudino; Paolo Cavarzere; Martina Montagnana; Elisa Danese; Marco Benati; Diego Alberto Ramaroli; Sara Raimondi; Alice Giontella; Anna Mantovani; Angela Donato; Andrea Dalbeni; Pietro Minuz; Franco Antoniazzi; Claudio Maffeis; Cristiano Fava
Journal:  Eur J Nutr       Date:  2018-03-28       Impact factor: 5.614

3.  Fatty acid composition in serum cholesterol esters and phospholipids is linked to visceral and subcutaneous adipose tissue content in elderly individuals: a cross-sectional study.

Authors:  Fredrik Rosqvist; Helena Bjermo; Joel Kullberg; Lars Johansson; Karl Michaëlsson; Håkan Ahlström; Lars Lind; Ulf Risérus
Journal:  Lipids Health Dis       Date:  2017-04-04       Impact factor: 3.876

4.  Serum Phospholipid Fatty Acids Levels, Anthropometric Variables and Adiposity in Spanish Premenopausal Women.

Authors:  María Del Pilar Del Pozo; Virginia Lope; Inmaculada Criado-Navarro; Roberto Pastor-Barriuso; Nerea Fernández de Larrea; Emma Ruiz; Adela Castelló; Pilar Lucas; Ángeles Sierra; Isabelle Romieu; Véronique Chajès; Feliciano Priego-Capote; Beatriz Pérez-Gómez; Marina Pollán
Journal:  Nutrients       Date:  2020-06-25       Impact factor: 5.717

5.  Association between Obesity and Omega-3 Status in Healthy Young Women.

Authors:  Isabel E Young; Helen M Parker; Rebecca L Cook; Nicholas J O'Dwyer; Manohar L Garg; Kate S Steinbeck; Hoi Lun Cheng; Cheyne Donges; Janet L Franklin; Helen T O'Connor
Journal:  Nutrients       Date:  2020-05-20       Impact factor: 5.717

6.  Erythrocyte Membrane Nanomechanical Rigidity Is Decreased in Obese Patients.

Authors:  Jesús Sot; Aritz B García-Arribas; Beatriz Abad; Sara Arranz; Kevin Portune; Fernando Andrade; Alicia Martín-Nieto; Olaia Velasco; Eunate Arana; Itziar Tueros; Carla Ferreri; Sonia Gaztambide; Félix M Goñi; Luis Castaño; Alicia Alonso
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

Review 7.  Effects of Dietary α-Linolenic Acid Treatment and the Efficiency of Its Conversion to Eicosapentaenoic and Docosahexaenoic Acids in Obesity and Related Diseases.

Authors:  Marija Takic; Biljana Pokimica; Gordana Petrovic-Oggiano; Tamara Popovic
Journal:  Molecules       Date:  2022-07-13       Impact factor: 4.927

8.  Complex Interactions Between Circulating Fatty Acid Levels, Desaturase Activities, and the Risk of Gestational Diabetes Mellitus: A Prospective Cohort Study.

Authors:  Yue Liu; Yin-Yin Xia; Ting Zhang; Yang Yang; Richard D Cannon; Toby Mansell; Boris Novakovic; Richard Saffery; Ting-Li Han; Hua Zhang; Philip N Baker
Journal:  Front Nutr       Date:  2022-07-11

9.  Correlations between Fatty Acid Profile and Body Fat Distribution in Postmenopausal Women-A Cross Sectional Study.

Authors:  Anna Maria Cybulska; Kamila Rachubińska; Karolina Skonieczna-Żydecka; Arleta Drozd; Jolanta Pawlik; Ewa Stachowska; Aneta Cymbaluk-Płoska; Elżbieta Grochans
Journal:  Nutrients       Date:  2022-09-18       Impact factor: 6.706

10.  Association between Serum Phospholipid Fatty Acid Levels and Adiposity among Lebanese Adults: A Cross-Sectional Study.

Authors:  Sahar G Yammine; Farah Naja; Hani Tamim; Mona Nasrallah; Carine Biessy; Elom K Aglago; Michèle Matta; Isabelle Romieu; Marc J Gunter; Lara Nasreddine; Véronique Chajès
Journal:  Nutrients       Date:  2018-09-25       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.